| Financial Year |
March 31 2023 |
| Monetary Funds |
79,670,544.82 |
| Held-for-trading Financial Assets |
284,470,505.86 |
| Notes Receivable |
19,073,800.08 |
| Accounts Receivable |
118,245,876.67 |
| Advances to Suppliers |
2,713,228.15 |
| Other Receivables |
336,242.44 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
87,666,831.68 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
234,475,969.39 |
| Total Current Assets |
873,650,913.35 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
201,068,630.66 |
| Under-construction Projects |
845,885.47 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
10,711,977.71 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
5,945,818.53 |
| Deferred Income Tax Assets |
8,631,142.00 |
| Other Non-Current Assets |
429,886.50 |
| Sub-Total of Non-Current Assets |
243,561,030.76 |
| Total Assets |
1,117,211,944.11 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
33,848,444.95 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
8,093,955.27 |
| Taxes Payable |
10,342,450.99 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
10,147,941.26 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
213,279.75 |
| Sub-Total of Current Liabilities |
64,286,685.65 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
14,064,331.37 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
25,408,338.84 |
| Total Liabilities |
89,695,024.49 |
| Paid-In Capital(Or Share Stock) |
211,029,901.00 |
| Capital Surplus |
366,253,070.94 |
| Surplus Reserve |
88,676,496.21 |
| LESS:Treasury Stock |
10,108,596.26 |
| Undistributed Profits |
371,666,047.73 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,027,516,919.62 |
| Owner's Equity（Stockholder's Equity） |
1,027,516,919.62 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,117,211,944.11 |
